BY VARINIA CALLEROS International Non-Proprietary Names (INNs) are names for pharmaceutical substances or active pharmaceutical ingredients recognised as public property. They are treated as generic names by international authorities, with around 8,000 published at present. The World Health Organisation (WHO) provides guidelines for its member states, of which Mexico is one, on the use of INNs […]
POR ALEJANDRO LUNA Y JUAN LUIS SERRANO LIFE SCIENCE IP FOCUS, 8TH EDITION, MANAGING INTELLECTUAL PROPERTY 2010 MEXICO’S DRUG REGULATORS ARE PREPARING TO ISSUE NEW RULES ON BIOCOMPARABLE DRUGS. Mexico’s General Health Law was reformed on June 11 2009 in ways that will have an important impact on patent owners within the pharmaceutical and life sciences industries. […]
POR ARMANDO ARENAS INTERNATIONAL BRIEFINGS, MANAGING INTELLECTUAL PROPERTY, OCTOBER 2010 According to the current wording of the Mexican IP Law, injunctions can be imposed during the course of an infringement action related to trademarks, patents or slogans, and the plaintiff has to post a bond of an amount fixed by the Patent of Trade Mark Office […]
POR ROMMY MORALES INTERNATIONAL BRIEFINGS, MANAGING INTELLECTUAL PROPERTY, SEPTEMBER 2010 Article 19, section VII of the Mexican Industrial Property Law establishes, inter alia, that methods of therapeutic treatment applicable to the human body and to animals shall not be considered as inventions; as a result, such methods are expressly excluded from patentability. However, under Mexican law and […]
BY GEORGINA FLORES In order to update the means of receiving documentation, the Mexican Patent Office (IMPI) has amended the Rules for filing applications by means of an Act published on March 18 2010 in the Official Gazette. The Act is effective from the following day. Relevant issues in this Act include those referred to in […]
